{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "d07146b6-b99d-432a-9e36-a515460a7f02", "code": "P21917", "type": "PRIMARY", "url": "http://www.uniprot.org/uniprot/P21917?sort=score", "code_system": "UNIPROT", "references": [ "8cc9c92c-9d4d-42a3-9b14-e0e478c81c5f" ] }, { "uuid": "646fd753-7516-4e04-8141-532539d0331c", "code": "P21917", "type": "PRIMARY", "url": "https://pharos.nih.gov/idg/search?q=P21917", "code_system": "PHAROS", "references": [ "8cc9c92c-9d4d-42a3-9b14-e0e478c81c5f" ] }, { "uuid": "195f064b-82c6-4ec8-821f-cbfab5370b87", "code": "RI471QC62V", "type": "PRIMARY", "code_system": "FDA UNII" } ], "substance_class": "protein", "references": [ { "uuid": "cdcb2228-de5b-4f7b-a1d7-417e6cdb5f7c", "citation": "http://www.uniprot.org/uniprot/P21917", "url": "http://www.uniprot.org/uniprot/P21917", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "2d622650-adec-42da-93ad-9788f94ee310", "citation": "UNIPROT", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "4f120637-0239-4703-a99f-6cb1fe1b454f", "citation": "http://www.uniprot.org/uniprot/P21917?sort=score", "url": "http://www.uniprot.org/uniprot/P21917?sort=score", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8cc9c92c-9d4d-42a3-9b14-e0e478c81c5f", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493393474000, "tags": [ "NOMEN" ] }, { "uuid": "23170126-86a6-4845-91e6-c78b891abcd0", "citation": "Kim, Hye-Jung, et al. \"Classification of dopamine antagonists using functional feature hypothesis and topological descriptors.\" Bioorganic & medicinal chemistry 14.5 (2006): 1454-1461.", "url": "https://www.sciencedirect.com/science/article/pii/S096808960500951X", "doc_type": "JA", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "POT" ] }, { "uuid": "3c6e6ad5-ae67-468e-9e91-fd5a403b1226", "citation": "Belliotti, Thomas R., et al. \"A series of 6-and 7-piperazinyl-and-piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agent.\" Journal of medicinal chemistry 42.25 (1999): 5181-5187.", "url": "https://pubs.acs.org/doi/10.1021/jm990277d", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "POT", "SYNTH" ] }, { "uuid": "2ef5f908-280d-4aa1-a664-48a887f29f78", "citation": "https://www.drugbank.ca/drugs/DB00714#BE0000581", "doc_type": "WEBSITE", "public_domain": true }, { "uuid": "dc2dcb65-7edf-43d2-a694-099e1072cbed", "citation": "Corena-McLeod, Maria. \"Comparative pharmacology of risperidone and paliperidone.\" Drugs in R&D 15.2 (2015): 163-174.", "url": "https://link.springer.com/article/10.1007/s40268-015-0092-x", "doc_type": "JA", "public_domain": true }, { "uuid": "57cbe264-620d-4401-b905-de778bb9a988", "citation": "Corena-McLeod, Maria. \"Comparative pharmacology of risperidone and paliperidone.\" Drugs in R&D 15.2 (2015): 163-174.", "url": "https://link.springer.com/article/10.1007/s40268-015-0092-x", "doc_type": "JA", "public_domain": true }, { "uuid": "f3939808-4644-43c5-b0a4-500992e4f6db", "citation": "Corena-McLeod, Maria. \"Comparative pharmacology of risperidone and paliperidone.\" Drugs in R&D 15.2 (2015): 163-174.", "url": "https://link.springer.com/article/10.1007/s40268-015-0092-x", "doc_type": "JA", "public_domain": true }, { "uuid": "16a4fc78-85d7-4a14-abf2-ecde10029c98", "citation": "Chiò, Adriano, Letizia Mazzini, and Gabriele Mora. \"Disease-modifying therapies in amyotrophic lateral sclerosis.\" Neuropharmacology 167 (2020): 107986.", "url": "https://www.sciencedirect.com/science/article/pii/S0028390820300526", "doc_type": "JA", "public_domain": true }, { "uuid": "675a6568-871c-4e01-8b6f-75f1459d054d", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a5550833-8f62-40d0-8d94-d89adb17b142", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "3bb0a33e-6642-4940-826e-d25adff3235a", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c87e5b52-d101-4819-8e3e-bf8df940e3ff", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e8cc8080-190c-45dd-8f29-14c46b69d489", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "97bd2567-64d4-4408-81b4-490ff8256617", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "3d63b692-281d-4bbc-8265-50c4ac7880cc", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "41d6c396-66ec-4442-8d59-da214cc8f0b8", "citation": "Nichols, David E., et al. \"Lysergamides of isomeric 2, 4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N, N-diethyllysergamide (LSD).\" Journal of Medicinal Chemistry 45.19 (2002): 4344-4349.", "url": "https://pubs.acs.org/doi/pdf/10.1021/jm020153s", "doc_type": "JA", "public_domain": true }, { "uuid": "95901a49-2e55-4b32-9836-4548f9a135fe", "citation": "Bourne, James A. \"SCH 23390: the first selective dopamine D1‐like receptor antagonist.\" CNS drug reviews 7.4 (2001): 399-414.", "url": "https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2001.tb00207.x?sid=nlm%3Apubmed", "doc_type": "JA", "public_domain": true }, { "uuid": "d6bad6c5-e0e1-4a14-b7d8-096494003d77", "citation": "https://drugs.ncats.io/drug/38QJ762ET6", "url": "https://drugs.ncats.io/drug/38QJ762ET6", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8d7cbe6d-0f29-4c3a-bd41-770a4b53cedf", "citation": "Bourne, James A. \"SCH 23390: the first selective dopamine D1‐like receptor antagonist.\" CNS drug reviews 7.4 (2001): 399-414.", "url": "https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2001.tb00207.x?sid=nlm%3Apubmed", "doc_type": "JA", "public_domain": true }, { "uuid": "24451a04-34be-43ee-a192-da05ef7ab838", "citation": "Bourne, James A. \"SCH 23390: the first selective dopamine D1‐like receptor antagonist.\" CNS drug reviews 7.4 (2001): 399-414.", "url": "https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2001.tb00207.x?sid=nlm%3Apubmed", "doc_type": "JA", "public_domain": true } ], "definition_type": "PRIMARY", "definition_level": "COMPLETE", "uuid": "ea992769-afc0-4ea1-a836-2b3c94ce32cd", "version": "33", "unii": "RI471QC62V", "relationships": [ { "uuid": "0d59233a-123f-4a22-a84a-c7ee015d4474", "amount": { "uuid": "7f16acf5-fc18-4d9f-9dd7-de6459aaecd1", "average": 4.4, "units": "NANOMOLAR" }, "comments": "Emax 45% Emax 82% Transfected CHO cells", "qualification": "EC50", "type": "AGONIST->TARGET", "references": [ "2ef5f908-280d-4aa1-a664-48a887f29f78" ], "related_substance": { "uuid": "ff988c9f-b53b-4370-a148-4c22bb1a0495", "refuuid": "d5382a9f-4b7e-432d-bf4d-03a5473c8f22", "name": "APOMORPHINE", "unii": "N21FAR7B4S", "linking_id": "N21FAR7B4S", "ref_pname": "APOMORPHINE" } }, { "uuid": "ce8ba808-cc78-47d9-a965-19ee71d21ee8", "amount": { "uuid": "b060c06c-cfba-4221-b3a0-9bd6db093109" }, "type": "PARTIAL AGONIST->TARGET", "related_substance": { "uuid": "18982661-5030-4722-8426-8a30e29d1120", "refuuid": "290d9815-8602-4636-ab28-7497ef98895b", "name": "Brilaroxazine", "unii": "X8L60BA01I", "linking_id": "X8L60BA01I", "ref_pname": "Brilaroxazine" } }, { "uuid": "d7905e1e-7017-4918-982b-7d9ffc391ac2", "amount": { "uuid": "a7375dd0-532d-47fb-8150-3be9841b58aa" }, "type": "AGONIST->TARGET", "related_substance": { "uuid": "660da504-9623-45a5-8c72-a97d02cec097", "refuuid": "23ecdee4-0740-40b6-b006-395ed0d40ac6", "name": "ROTIGOTINE", "unii": "87T4T8BO2E", "linking_id": "87T4T8BO2E", "ref_pname": "ROTIGOTINE" } }, { "uuid": "99d384b7-897d-4be7-87fc-b95374644e5c", "amount": { "uuid": "7e7d0637-c871-4073-8836-eca5b4cee32e" }, "type": "AGONIST->TARGET", "related_substance": { "uuid": "14f9855c-4dd6-43b4-957c-66312408f410", "refuuid": "4dae9454-8311-4528-8b18-4d4a3f4e6d32", "name": "PRAMIPEXOLE", "unii": "83619PEU5T", "linking_id": "83619PEU5T", "ref_pname": "PRAMIPEXOLE" } }, { "uuid": "7f2d2a25-3a99-4d38-8b07-d7758e64848e", "amount": { "uuid": "d3731797-5747-43ba-bd9d-6a6f7c80fe2b", "average": 13.9, "high": 22, "low": 5.8, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "ACTIVATOR->TARGET", "interaction_type": "INHIBITOR", "references": [ "57cbe264-620d-4401-b905-de778bb9a988" ], "related_substance": { "uuid": "4ad294d2-272f-41b2-9e95-96c25a55cd63", "refuuid": "95270949-f3d1-440d-8635-faa62495c858", "name": "RISPERIDONE", "unii": "L6UH7ZF8HC", "linking_id": "L6UH7ZF8HC", "ref_pname": "RISPERIDONE" } }, { "uuid": "62c017f0-3458-4c31-812d-6ca3ada6b790", "amount": { "uuid": "ec3086b6-6b18-415e-ad22-5d464f4c7d7e", "average": 21, "high": 38, "low": 5.4, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "interaction_type": "INHIBITOR ", "references": [ "f3939808-4644-43c5-b0a4-500992e4f6db" ], "related_substance": { "uuid": "476a32a0-7751-41cb-98af-983430e24848", "refuuid": "d8f372eb-a89e-47ec-a957-bcdb1111df0b", "name": "PALIPERIDONE", "unii": "838F01T721", "linking_id": "838F01T721", "ref_pname": "PALIPERIDONE" } }, { "uuid": "18472e20-5deb-46f0-998e-90f2e1be0ebd", "type": "INHIBITOR->TARGET", "references": [ "23170126-86a6-4845-91e6-c78b891abcd0", "3c6e6ad5-ae67-468e-9e91-fd5a403b1226" ], "related_substance": { "uuid": "a9b91b42-a894-460f-a811-4b7954317482", "refuuid": "5a22e3e5-da61-4fe9-ad0c-a6caaf8dc6a9", "name": "PD-172760", "unii": "G7FMS28PYD", "linking_id": "G7FMS28PYD", "ref_pname": "PD-172760" } }, { "uuid": "592e66f6-0d69-4200-81fd-2c31d2ee826a", "amount": { "uuid": "cc87398e-e50c-42bb-836e-399c039a8e9e", "average": 2.4, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "RADIOLIGAND->TARGET", "related_substance": { "uuid": "72446aa5-839f-446e-a5b5-9b0e54afe8c6", "refuuid": "37b19c8c-900c-4d9c-9936-fc72ae215cfe", "name": "WAY-100635 C-11", "unii": "3YQY8P5QGX", "linking_id": "3YQY8P5QGX", "ref_pname": "WAY-100635 C-11", "substance_class": "reference" } }, { "uuid": "5a4a599c-2fb5-43f9-a8f8-41c5a8c2c202", "amount": { "uuid": "9f00ed7a-b1dd-419c-a7a0-27ac1b6a2861" }, "type": "AGONIST->TARGET", "references": [ "3d63b692-281d-4bbc-8265-50c4ac7880cc" ], "related_substance": { "uuid": "2aed660c-b2eb-4417-b250-47c27acd5275", "refuuid": "f51c196c-6cf2-4e95-a3ea-435b44b0bd57", "name": "6-FLUORO-DMT", "unii": "J4CZH8D9EN", "linking_id": "J4CZH8D9EN", "ref_pname": "6-FLUORO-DMT" } }, { "uuid": "8a51cc31-e4e1-4424-b76d-9ce070d92176", "amount": { "uuid": "420eaea8-2096-46eb-a882-bb067d9b9f1d" }, "type": "INHIBITOR->TARGET", "references": [ "16a4fc78-85d7-4a14-abf2-ecde10029c98" ], "related_substance": { "uuid": "7ab18d67-b0af-4b48-9913-932aa38b7ded", "refuuid": "853e38c8-ffda-4379-bfb6-e8bf16b17b6a", "name": "PIMOZIDE", "unii": "1HIZ4DL86F", "linking_id": "1HIZ4DL86F", "ref_pname": "PIMOZIDE", "substance_class": "reference" } }, { "uuid": "f70e6409-18ab-4f63-9c8f-8718c1fb3187", "amount": { "uuid": "639c11e9-b47e-4b40-806e-063272a85f09" }, "type": "AGONIST->TARGET", "references": [ "c87e5b52-d101-4819-8e3e-bf8df940e3ff" ], "related_substance": { "uuid": "61c776e0-41d3-4ca7-a486-f91d19346f2a", "refuuid": "0e560c36-3c0d-4b31-8cca-85568f874636", "name": "PD-168077", "unii": "2A5XS99U8Q", "linking_id": "2A5XS99U8Q", "ref_pname": "PD-168077" } }, { "uuid": "08c729b9-bd80-4933-88a1-97d387e7a8fb", "amount": { "uuid": "a14c15e3-7c95-41b6-9594-a8b54e380d96" }, "type": "AGONIST->TARGET", "references": [ "97bd2567-64d4-4408-81b4-490ff8256617" ], "related_substance": { "uuid": "b9bb866a-59d2-4859-ad15-3e98ae5d24b3", "refuuid": "b714e0ee-d080-4552-924e-a8a46a576f43", "name": "DINOXYLINE", "unii": "9T7B8CV47A", "linking_id": "9T7B8CV47A", "ref_pname": "DINOXYLINE" } }, { "uuid": "a367d33e-8eed-4790-8d59-d1fcf83bac18", "amount": { "uuid": "f8815471-5ef2-4ae7-954f-42a5aacab354", "average": 2.4, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "RADIOLIGAND->TARGET", "related_substance": { "uuid": "8975585c-ef91-4e2f-9a7a-6210b8850b98", "refuuid": "cc5bfbdc-39d9-4201-b541-39dd0f85ed56", "name": "WAY-100635 CARBONYL-C-11", "unii": "DAV805YGOX", "linking_id": "DAV805YGOX", "ref_pname": "WAY-100635 CARBONYL-C-11", "substance_class": "reference" } }, { "uuid": "175151aa-52d1-4a6e-955c-51488056f317", "amount": { "uuid": "85888569-20d3-46c0-a1b5-c138e2a78e74", "average": 2.4, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "AGONIST->TARGET", "related_substance": { "uuid": "39daf785-ee25-475f-905c-230311b324d5", "refuuid": "c20c4989-de87-4e49-aeac-53c408ce8565", "name": "WAY-100635", "unii": "71IH826FEG", "linking_id": "71IH826FEG", "ref_pname": "WAY-100635", "substance_class": "reference" } }, { "uuid": "54a9c208-4c40-4206-bc3f-04cc0b92d050", "amount": { "uuid": "e6fefa0c-2bda-471b-b248-0433f4964a91" }, "type": "AGONIST->TARGET", "references": [ "3bb0a33e-6642-4940-826e-d25adff3235a" ], "related_substance": { "uuid": "f229a576-4c60-4013-9636-4b717a72162e", "refuuid": "a6c42e70-934f-4dd3-8814-4b62946d3628", "name": "RO-10-5824", "unii": "8X35VUU4YY", "linking_id": "8X35VUU4YY", "ref_pname": "RO-10-5824" } }, { "uuid": "ef774228-c4fb-4bb7-922f-99a9adf30ad4", "amount": { "uuid": "2f7f24fd-b8b7-4ada-a915-f80d1bf700f2" }, "type": "AGONIST->TARGET", "references": [ "675a6568-871c-4e01-8b6f-75f1459d054d" ], "related_substance": { "uuid": "ab0a2173-7a64-4591-8b0d-d628a741c0df", "refuuid": "7e539b49-39f2-4a52-917b-91759cb6ac86", "name": "CP-226269", "unii": "WX4CVT9DYH", "linking_id": "WX4CVT9DYH", "ref_pname": "CP-226269" } }, { "uuid": "81fd702d-1527-43f9-aad1-c8eb3219fa6d", "amount": { "uuid": "dc8b2974-85bb-44d6-9430-28586048b306", "average": 2.93, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "d6bad6c5-e0e1-4a14-b7d8-096494003d77" ], "related_substance": { "uuid": "06451ad4-d048-4073-a591-bd92afe30b51", "refuuid": "60043ec9-15fe-4d4d-b57a-a6e7eb144b25", "name": "FANANSERIN", "unii": "38QJ762ET6", "linking_id": "38QJ762ET6", "ref_pname": "FANANSERIN", "substance_class": "reference" } }, { "uuid": "85a81047-ce27-4e92-9cca-330f78e37b7d", "amount": { "uuid": "8826463f-0d20-4e71-af43-c9c09c7a07ff", "average": 56, "high": 68, "low": 44, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "LIGAND->OFF TARGET", "interaction_type": "BINDING", "references": [ "41d6c396-66ec-4442-8d59-da214cc8f0b8" ], "related_substance": { "uuid": "ce7d66f1-18b6-4145-9886-76af5ff79f91", "refuuid": "47838978-2214-4228-a38b-9ed5b1b283a3", "name": "LYSERGIDE", "unii": "8NA5SWF92O", "linking_id": "8NA5SWF92O", "ref_pname": "LYSERGIDE", "substance_class": "reference" } }, { "uuid": "7a036a1a-3581-4465-9585-e6cba1103fa2", "amount": { "uuid": "09eed082-4064-4d47-b231-83df8b2f81b7" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "d613194a-746a-4256-a4c8-def966312c5f", "refuuid": "0496ae22-2206-4a25-a261-368169e003b3", "name": "SONEPIPRAZOLE", "unii": "O609V24217", "linking_id": "O609V24217", "ref_pname": "SONEPIPRAZOLE", "substance_class": "reference" } }, { "uuid": "acddfc5d-e056-4537-9cd9-94cc0561490f", "amount": { "uuid": "5705f043-255f-4f6d-8209-5c3dec8ced5e", "average": 30, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "AGONIST->TARGET", "references": [ "24451a04-34be-43ee-a192-da05ef7ab838" ], "related_substance": { "uuid": "1eeec8b6-4a53-44de-a26d-708e22faf7c4", "refuuid": "11cfc6b9-4651-4a5c-98b9-284d8fbe2b50", "name": "DOPAMINE", "unii": "VTD58H1Z2X", "linking_id": "VTD58H1Z2X", "ref_pname": "DOPAMINE", "substance_class": "reference" } }, { "uuid": "16af8db2-6d41-49b4-afc2-2337e7632988", "amount": { "uuid": "ef808667-9aae-4551-8a29-acca90055950", "average": 3, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->OFF-TARGET", "references": [ "95901a49-2e55-4b32-9836-4548f9a135fe" ], "related_substance": { "uuid": "979fca6f-5e0d-44fb-a938-501af533e1b7", "refuuid": "13369292-c650-4ac4-be6a-dadb9d87a173", "name": "SCH-23390", "unii": "UGT5535REQ", "linking_id": "UGT5535REQ", "ref_pname": "SCH-23390", "substance_class": "reference" } }, { "uuid": "45c16735-1589-4c01-a733-7db84414409d", "amount": { "uuid": "f2bacef8-e87b-472b-ab3d-2837302e3c93", "average": 2.3, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "8d7cbe6d-0f29-4c3a-bd41-770a4b53cedf" ], "related_substance": { "uuid": "ae875047-8e05-40d3-a811-882a43d77559", "refuuid": "cb034a38-8a43-4112-9760-cae598710d66", "name": "HALOPERIDOL", "unii": "J6292F8L3D", "linking_id": "J6292F8L3D", "ref_pname": "HALOPERIDOL", "substance_class": "reference" } } ], "names": [ { "uuid": "65dc2446-4393-b979-bbe3-8fec025e0c53", "name": "D(2C) DOPAMINE RECEPTOR", "stdName": "D(2C) DOPAMINE RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "cdcb2228-de5b-4f7b-a1d7-417e6cdb5f7c" ], "display_name": false }, { "uuid": "a0c4e88b-23fd-412a-b15d-21f698f1e9a8", "name": "D(4) DOPAMINE RECEPTOR", "stdName": "D(4) DOPAMINE RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d622650-adec-42da-93ad-9788f94ee310", "cdcb2228-de5b-4f7b-a1d7-417e6cdb5f7c" ], "display_name": true }, { "uuid": "b9487269-0b69-4192-adc9-5ca599f88949", "name": "D4", "stdName": "D4", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "cdcb2228-de5b-4f7b-a1d7-417e6cdb5f7c" ], "display_name": false }, { "uuid": "356ee456-5d22-4096-afdd-2aad97999bc0", "name": "D4 DOPAMINE RECEPTOR", "stdName": "D4 DOPAMINE RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4f120637-0239-4703-a99f-6cb1fe1b454f" ], "display_name": false }, { "uuid": "894956ce-dd11-4c13-974e-4843f02688e4", "name": "DOPAMINE RECEPTOR D4", "stdName": "DOPAMINE RECEPTOR D4", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "8cc9c92c-9d4d-42a3-9b14-e0e478c81c5f" ], "display_name": false }, { "uuid": "5621f4f8-8803-4e47-86b4-ab3b98c86139", "name": "DRD4", "stdName": "DRD4", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d622650-adec-42da-93ad-9788f94ee310", "4f120637-0239-4703-a99f-6cb1fe1b454f" ], "display_name": false } ], "protein": { "uuid": "193d9466-82bd-4894-a2e9-7ff6033e583e", "glycosylation": { "uuid": "9df36b8a-aa98-4835-9bec-c040ab2dacbf", "glycosylation_type": "HUMAN", "n_glycosylation_sites": [ { "residue_index": 3, "subunit_index": 1 } ] }, "subunits": [ { "uuid": "b9fa5ec8-2998-45a2-b718-6feffc2479e2", "sequence": "MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPGLPPDPCGPDCAPPAPGLPQDPCGPDCAPPAPGLPRGPCGPDCAPPAPGLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC", "subunit_index": 1 } ], "references": [ "cdcb2228-de5b-4f7b-a1d7-417e6cdb5f7c" ], "disulfide_links": [ { "sites": [ { "residue_index": 108, "subunit_index": 1 }, { "residue_index": 185, "subunit_index": 1 } ] } ], "protein_sub_type": "", "sequence_origin": "HUMAN", "sequence_type": "COMPLETE" }, "properties": [ { "uuid": "95c5a00c-b633-4408-bd5b-7e6ad1cd5164", "name": "MOL_WEIGHT", "type": "amount", "value": { "uuid": "437545d5-0499-48dc-b34b-c0d47f34f4ea", "units": "DA" }, "defining": false, "property_type": "CHEMICAL" }, { "uuid": "abe8371c-22cc-4736-bb68-fc40eab33fd1", "name": "Molecular Formula", "value": { "uuid": "3b85a059-e90b-4574-bc9c-f83fbbf11045", "type": "ESTIMATED", "non_numeric_value": "C2150H3413N612O591S33" }, "defining": false, "property_type": "CHEMICAL" } ], "modifications": { "uuid": "df9dd825-34b0-4c8c-911e-bd9deb837361" } } ] }